Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-12-02

Clinical Trial Update: Immune Benefits of Coffee [NA]

View source ↗

Summary

A completed clinical trial investigated the immune benefits of coffee, with a focus on immune senescence and low-grade inflammation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Coffee (caffeine-containing beverage)

Snippet

Sponsor: University of Chile | Conditions: Immune Senescence, Low-grade Inflammation | NA | Status: COMPLETED